The FDA granted conditional approval of medical diagnostic company Check-Cap’s investigational device exemption application to begin a pilot study of the company’s C-Scan system. 1. The conditional ...
Patients who underwent the procedure, as part of the 2019 U.S. pilot study, were significantly more likely to recommend C-Scan test compared to colonoscopy ISFIYA, Israel, Nov. 22, 2021 /PRNewswire/ - ...
ISFIYA, Israel, March 15, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results